Comparison of VA and D/IA Induction Regimens in Elderly Fit Acute Myeloid Leukemia Patients

NCT07132684 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

240

Enrollment

OTHER

Sponsor class

Conditions

AML, Adult

Interventions

DRUG: Daunorubicin/Idarubicin
DRUG: Cytarabine
DRUG: Azacitidine
DRUG: Venetoclax

Sponsor

Institute of Hematology & Blood Diseases Hospital, China